Researchers Test "Killer" Enzyme as Anthrax Treatment
By Gerry J. Gilmore
American Forces Press Service
WASHINGTON, Jan. 29, 2003 -- An anthrax-killing enzyme now
being tested by the Defense Department may one day be used
as a medical treatment against the deadly bacteria, a DoD
researcher said.
The enzyme, lysin, "is like a 'smart bomb' that kills
anthrax, but doesn't kill anything else," noted Dr. John
Carney, a pharmacologist with the Defense Advanced Research
Projects Agency in Arlington, Va. "This could be an unique
treatment (against anthrax) that wouldn't cause side
effects."
Carney has worked three years with DARPA-contracted
research microbiologists at Rockefeller University in New
York, in developing more effective medical therapy for
anthrax.
Lysin attacks anthrax by dissolving a hole in the bacteria
from the inside out, Carney explained. Water surrounding
the ruptured anthrax cell rushes in, he continued, causing
it to burst.
Persons can receive vaccinations for protection against
anthrax, Carney pointed out, while Cipro, doxycycline,
penicillin and other antibiotics are used as treatment for
unvaccinated people who've been, or may have been, exposed
to the bacteria. Yet, some persons might be allergic to the
antibiotics used to battle anthrax, he acknowledged.
In addition, he said, broad-spectrum antibiotics are
indiscriminate. They kill all bacteria, even beneficial
ones, and that can cause side effects such as diarrhea. He
said the new enzyme, on the other hand, has the potential
for fewer side effects because it would kill only anthrax
bacteria,
Carney noted he and his associates have great hopes for the
experimental enzyme therapy. Human testing, he said, is on
the horizon.
"It's getting close," he emphasized, "It's been proven in
rodent studies that it works." The clinical studies, Carney
pointed out, are reviewed by the Food and Drug
Administration, which would provide final approval for any
new anthrax treatment procedure.
Anthrax makes a deadly biological weapon of mass
destruction, Carney noted. After a person is exposed to
anthrax bacteria, "it grows in your body," he pointed out,
and releases several toxic proteins -- poisons.
Those poisons travel through the victim's blood stream and
attack and destroy the body's immune system, Carney
explained, hampering the body's ability to resist
infections.
Untreated anthrax victims develop "an abnormal pneumonia,"
Carney pointed out -- the first clinical sign of the
bacteria's presence. As the poisons spread, they "weaken
your body and, ultimately, your organs fail and you die,"
he noted.
Cattle can contract anthrax, Carney explained, because
"it's found in the dirt." Sheep farmers, he added, have
contracted anthrax by breathing in spores coming off
infected animals' wool.
Carney ticked off the three forms of anthrax:
gastrointestinal, cutaneous or skin, and pulmonary. Eating
infected dirt causes gastro-intestinal anthrax, he
explained, while cutaneous anthrax enters the body through
a break or cut in the skin.
Inhaling anthrax spores, Carney pointed out, causes the
pulmonary variety of the disease. Becoming a spore, he
noted, is one of the things the organism does to survive.
"Cutaneous anthrax is treatable; it's not a lethal
disease," Carney explained, adding that gastrointestinal
anthrax "is very uncomfortable, but is rarely, if ever,
lethal."
Pulmonary anthrax, however, "is a much worse disease -- and
it's lethal," he concluded.
|